Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ·Healthcare·Biotechnology
$9.21
-3.40%
Mkt Cap $1.22B
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (25 analysts)
$36.67
Range $31.00 – $46.00
Implied Upside
+298.2%
Consensus $36.67 vs current $9.21
NASDAQ·Healthcare·Biotechnology
$9.21
-3.40%
Mkt Cap $1.22B
Buy
9
Hold
0
Sell
0
Price Target (25 analysts)
$36.67
Range $31.00 – $46.00
+298.2%
Consensus $36.67 vs current $9.21